Skip to Content

Health Sciences Group Inc HESG

Morningstar Rating
$0.00 0.00 (900.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HESG is trading at a 3% premium.
Price
$0.00
Fair Value
$6.89
Uncertainty
Extreme
1-Star Price
$2.64
5-Star Price
$4.62
Economic Moat
Gmtpbz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HESG is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$562.94
Volume/Avg
1,500 / 2.7 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Health Sciences Group Inc identifies, develops, and commercializes nutritional products. Its products are targeted towards consumers and medical professionals interested in preventative healthcare alternatives. The products are sold as nutritional supplements and functional ingredients to retail and wholesale customers in the nutrition, skin care, and food industries. The company distributes its products under the Swiss Research™ and Swiss Diet™ brand names.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
2
Website

Valuation

Metric
HESG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
HESG
Quick Ratio
0.00
Current Ratio
0.01
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
HESG
Return on Assets (Normalized)
−90.07%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRLvfg$537.7 Bil
VRTX
Vertex Pharmaceuticals IncZkjnzcg$108.4 Bil
REGN
Regeneron Pharmaceuticals IncCgsgff$104.6 Bil
MRNA
Moderna IncCckf$33.4 Bil
ARGX
argenx SE ADRWtkv$23.7 Bil
BNTX
BioNTech SE ADRFwyy$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncJpnnww$19.5 Bil
BMRN
Biomarin Pharmaceutical IncCqrsfq$16.7 Bil
RPRX
Royalty Pharma PLC Class AWtyxvg$14.0 Bil
INCY
Incyte CorpYddlj$13.5 Bil

Sponsor Center